About Melatech
Melatech is a company based in Copenhagen (Denmark) founded in 2018 by Niels Steen Krogh and Niels Kvorning Ternov. Melatech has raised $573.99 thousand across 2 funding rounds from investors including Accelerace and Nicolaj Højer Nielsen. The company has 31 employees as of November 30, 2024. Melatech offers products and services including Dermloop, Dermkit, and Dermloop Learn. Melatech operates in a competitive market with competitors including Syapse, BostonGene, VieCure, Kuveda and Myka Labs, among others.
- Headquarter Copenhagen, Denmark
- Employees 31 as on 30 Nov, 2024
- Founders Niels Steen Krogh, Niels Kvorning Ternov
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Melatech Aps
-
Annual Revenue
$6.82 K (USD)0as on Dec 31, 2019
-
Net Profit
$431.33 K (USD)299as on Dec 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$573.99 K (USD)
in 2 rounds
-
Latest Funding Round
$466.42 K (USD), Seed
Nov 30, 2022
-
Investors
Accelerace
& 1 more
-
Employee Count
31
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Melatech
Melatech offers a comprehensive portfolio of products and services, including Dermloop, Dermkit, and Dermloop Learn.
Software for managing skin conditions and enhancing clinical workflows.
Device for capturing high-quality images of skin lesions.
Platform for practicing skin lesion diagnostics using real cases.
Funding Insights of Melatech
Melatech has successfully raised a total of $573.99K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $466.42 thousand completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Melatech
Melatech has secured backing from 2 investors, including angel and venture fund investors. Prominent investors backing the company include Accelerace and Nicolaj Højer Nielsen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding and support are provided to early-stage startups by Accelerace.
|
Locked | Locked | Locked | |
|
NH
Nicolaj Højer Nielsen |
-
|
Locked | Locked | Locked |
Investor details for Melatech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Melatech
Investment portfolio details for Melatech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Melatech
Detailed financials for Melatech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Melatech Comparisons
Peer comparison for Melatech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Melatech
Melatech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syapse, BostonGene, VieCure, Kuveda and Myka Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of precision medicine for the treatment of cancer
|
|
| Locked | Locked | Locked |
Developer of cloud-based information and analytics platform to treat cancer
|
|
| Locked | Locked | Locked |
Oncology treatment plans are generated via an AI-based platform.
|
|
| Locked | Locked | Locked |
SaaS tools for analyzing cancer patients' molecular profiles are provided.
|
|
| Locked | Locked | Locked |
AI-based integrated solutions for interventional oncology procedures are provided.
|
Detailed competitors of Melatech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Melatech
Complete news archive for Melatech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Melatech
Melatech was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Melatech is headquartered in Copenhagen, Denmark.
Niels Kvorning Ternov is the current CEO of Melatech. They have also founded this company.
Melatech is a funded company, having raised a total of $573.99K across 2 funding rounds to date.
As of Nov 30, 2024, the latest employee count at Melatech is 31.
Annual revenue of Melatech is $6.82K as on Dec 31, 2019.
AI-based patient treatment management tool for providers. The company provides software solutions to improve patient treatment through optimized clinical workflows. The also offers AI-augmented simulation training, clinical feedback, and management in skin cancer diagnostics.
Melatech's top competitors include Syapse, BostonGene and VieCure.
Melatech offers Dermloop, Dermkit, and Dermloop Learn.
Melatech has 2 investors. Key investors include Accelerace, and Nicolaj Højer Nielsen.